Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study
published in: Journal of Clinical Medicine Research
date of publication: 2019-04
language: English
main subject: nivolumab
Cites articles 118
- 2018-03-11
- 2017-02-21
Date
Title
Article - wd:Q64080634